![glp 1 ddp4 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner dpp-4_inhibitors [TUSOM | Pharmwiki]](https://www.mclaren.org/Uploads/Public/Images/MPHO/ClinicalCorner_20210615_GLP_1.jpg)
glp 1 ddp4 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner dpp-4_inhibitors [TUSOM | Pharmwiki]
Description
GLP-1 as a treatment for weight loss seems to have become all the rage these days
![glp 1 ddp4 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner dpp-4_inhibitors [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/dpp4.png?w=600&tok=f9724b)
: !GLP-1 ,
![glp 1 ddp4 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner dpp-4_inhibitors [TUSOM | Pharmwiki]](https://i.ytimg.com/vi/FePjKBoFICA/maxresdefault.jpg)
Achieve sustainable results with our physician-led GLP-1 weight loss program
![glp 1 ddp4 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner dpp-4_inhibitors [TUSOM | Pharmwiki]](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01474-z/MediaObjects/12933_2022_1474_Fig4_HTML.png)
Louisianas Medicaid program could expand access to popular weight-loss medications such as Wegovy and Zepbound for obesity treatment starting in January.
![glp 1 ddp4 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner dpp-4_inhibitors [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S1537189111000577-gr1.jpg)
